SCHEMBL12694698

SCHEMBL12694698

Cc1cc(Nc2ncc(Cl)c(Nc3ccc4c(c3)N(C)CC(C)(C)O4)n2)cnc1N1CCN(C)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 12/20 0.53
▸ EGFR P00533 2/20 0.51
▸ CDK9 P50750 4/20 0.49
▸ CCNK O75909 3/20 0.49
▸ CCND3 P30281 3/20 0.49
▸ CDK6 Q00534 3/20 0.49
▸ CCNA2 P20248 1/20 0.49
▸ CDK2 P24941 1/20 0.49
▸ ALK Q9UM73 2/20 0.49
▸ TNK2 Q07912 2/20 0.48
▸ CHEK1 O14757 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ DAPK3 O43293 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ MAP4K4 O95819 1/20 0.47
▸ PAK4 O96013 1/20 0.47
▸ ABL1 P00519 1/20 0.47
▸ NTRK1 P04629 1/20 0.47
▸ LCK P06239 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12694656 0.88 CTSC (0.61) BRD4EGFRCDK9ALKTNK2
SCHEMBL12854655 0.87 EGFR (0.52) BRD4EGFRCDK9CCNKCCND3
SCHEMBL13268187 0.82 BRD4 (0.53) BRD4EGFRCDK9CCNKCCND3
SCHEMBL12694807 0.80 BRD4 (0.63) BRD4EGFRCDK9CCNKCCND3
SCHEMBL3112959 0.79 BRD4 (0.51) BRD4EGFRALKJAK2RET
SCHEMBL3115062 0.77 TNK2 (0.55) BRD4EGFRCDK9CCNKCCND3
SCHEMBL14481942 0.75 BRD4 (0.50) BRD4EGFRCDK2ALKTNK2
SCHEMBL3107379 0.74 BRD4 (0.65) BRD4EGFRCDK9CCNKCCND3
SCHEMBL3102212 0.74 JAK1 (0.60) BRD4EGFRJAK2JAK3
SCHEMBL12854649 0.74 CTSC (0.58) BRD4EGFRCDK9ALKTNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278299-B2 Pyrimidinediamine kinase inhibitors RIGEL PHARMACEUTICALS, INC. (US) 2012-10-02 — — US disclosed
Send feedback